Pre-screening survey to see who may qualify for future metabolic and mental health studies
Surveys adults with heart, weight, blood sugar or mental health conditions for future trials.
Key facts
- Who runs it
- Clindove Research LLC
- Where
- Brooklyn, United StatesSee the site
- Trial code
- Registry title
- Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- Status
- Recruiting
- People taking part
- 7,000 people, planned
- Started
- 30 Jul 2025
- Expected to end
- 1 Dec 2030
- Type of study
- Observational
- Treatments tested
- Blood Work
- Record updated
- 12 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who agree to a pre-screening survey. It checks if they could join future trials on metabolic, heart, weight, mental health or hormone conditions.
- Age
- 18 years and over
- Sex
- All sexes can join.
Main reasons for not taking part
- Pregnant or breastfeeding people
- Severe cognitive impairment or cannot give informed consent
- Acute psychiatric emergency needing immediate help or hospital care
- Taking part in another research study that conflicts with the pre-screening
- Known history of drug or alcohol misuse
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Any participant of age 18 years and over
- Who are willing to provide informed consent and participate in the pre-screening study and comply with study procedures
Who cannot take part
- Individuals having severe cognitive impairment or inability to provide informed consent
- Individuals having acute psychiatric emergencies requiring immediate intervention/hospitalization
- Individuals having known history of drug/alcohol misuse
- Individuals having medical conditions that, in the investigator's opinion, could compromise the integrity of the screening process or pose significant risks to the participant's health
- Pregnant or breastfeeding individuals
- Individuals who are currently participating in another research study that conflicts with pre-screening data collection
Where in United States
- Clindove Research LLCBrooklyn, United StatesContact: Nelly Cohen, MDTaking people
About the trial
What the trial wants to find out
DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study team may also collect basic health information, including vital signs, urine drug tests, blood samples and pregnancy tests (if applicable). A physician will review each participant's medical history in a one-on-one interview to assess potential fit for upcoming trials. If needed, the doctor may contact the participant's current doctors or pharmacies to gather more information for eligibility review.
The group in the trial
- All Participants
Participants undergoing metabolic and/or psychiatric assessments through blood work and structured clinical evaluations, as outlined in the study protocol.
Treatment: Blood Work
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pre-screening Survey for Metabolic, Cardiovascular, Obesity, Mental Health, and Endocrine Trial Eligibility (DOVE-MET-COME-100)
- Plain-language title
- Pre-screening survey to see who may qualify for future metabolic and mental health studiesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 12 August 2025